The business of metal health is banking on this growing concern in the general population. The statistics for the general population in regards to some form of depression are staggering and I would bet that there would be easily be only one of two separation before you know someone needing help.

Emyria Limited (ASX: EMD), a pioneer in evidence-based mental health care, has announced a strategic move into Queensland via a new agreement with Avive Health. This initiative marks the Company’s first Queensland-based clinic and a critical step in Emyria’s nationwide expansion strategy. The new clinic, to be located within Avive’s licensed 63-bed mental health hospital in Brisbane, will house an Empax Centre focused on treatment-resistant depression and Post-traumatic stres

Emyria Limited (ASX: EMD) embodies the fusion of compassionate care, groundbreaking science, and a market in dire need of change. Recently, the company has gained attention by uniquely creating a scalable, evidence-based model for psychedelic-assisted therapy within licensed medical settings in Australia.